MuchohiSNObieroKNewtonCR. Pharmacokinetics and clinical efficacy of lorazepam in children with severe malaria and convulsions. Br J Clin Pharmacol. 2008;65:12–21.
2.
AryaRGulatiSKabraM. Intranasal versus intravenous lorazepam for control of acute seizures in children: a randomized open-label study. Epilepsia. 2011;52:788–793.
3.
QureshiAwassemerEDaviesP. Comparative audit of intravenous lorazepam and diazepam in the emergency treatment of convulsive status epilepticus in children. Seizures. 2002;11:141–144.
4.
AndersonMTambePSammonsH. Pharmacokinetics of buccal and intranasal lorazepam in healthy adult volunteers. Eur J Clin Pharmacol. 2012;68:155–159.
5.
SrinivasNR. Buccal and intranasal lorazepam clinical pharmacokinetics: can it adequately compete with intravenous lorazepam in pediatric care patients?Eur J Clin Pharmacol. 2012;68:1221–1223.
6.
TroesterMMHastriterEVNgYT. Dissolving oral clonazepam wafers in the acute treatment of prolonged seizures. J Child Neurol. 2010;25:1468–1472.
7.
CloydJ. Pharmacologic consideration in the treatment of repetitive or prolonged seizures. J Child Neurol. 2007;22:47s–52s.
8.
WinklerASTluwayASchmutzhardE. Febrile seizures in rural Tanzania: hospital-based incidence and clinical characteristics. J Trop Pediatr. 2013;59:298–304.
